Cargando…
Hypoxia and TGF-β Drive Breast Cancer Bone Metastases through Parallel Signaling Pathways in Tumor Cells and the Bone Microenvironment
BACKGROUND: Most patients with advanced breast cancer develop bone metastases, which cause pain, hypercalcemia, fractures, nerve compression and paralysis. Chemotherapy causes further bone loss, and bone-specific treatments are only palliative. Multiple tumor-secreted factors act on the bone microen...
Autores principales: | Dunn, Lauren K., Mohammad, Khalid S., Fournier, Pierrick G. J., McKenna, C. Ryan, Davis, Holly W., Niewolna, Maria, Peng, Xiang Hong, Chirgwin, John M., Guise, Theresa A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731927/ https://www.ncbi.nlm.nih.gov/pubmed/19727403 http://dx.doi.org/10.1371/journal.pone.0006896 |
Ejemplares similares
-
Halofuginone inhibits TGF-β/BMP signaling and in combination with zoledronic acid enhances inhibition of breast cancer bone metastasis
por: Juárez, Patricia, et al.
Publicado: (2017) -
Tumor-expressed adrenomedullin accelerates breast cancer bone metastasis
por: Siclari, Valerie A, et al.
Publicado: (2014) -
The Role of TGF-β in Bone Metastases
por: Trivedi, Trupti, et al.
Publicado: (2021) -
Regulation of Postnatal Trabecular Bone Formation by the Osteoblast Endothelin A Receptor
por: Clines, Gregory A, et al.
Publicado: (2011) -
Role of TGF-β in breast cancer bone metastases
por: Chiechi, Antonella, et al.
Publicado: (2013)